drugset / Trial / NCT06254482
An Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease (HD)
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary goal of this study is to evaluate the long-term safety and pharmacodynamic effects of votoplam in participants with HD.
Timeline
- Start
- 2023-08-25
- Primary completion
- 2029-07-16
- Completion
- 2029-07-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Votoplam | Small molecule | 5 mg | Oral |
| Subject | Votoplam | Small molecule | 10 mg | Oral |